Shanghai OPM Biosciences Co (SHSE:688293) Operating Margin %: 8.16% (As of Mar. 2026) — 11% Below Median


SHSE:688293 Shanghai OPM Biosciences Co Ltd SHSE:688293
82 GF Score
Price ¥40.09
GF Value ¥37.48
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Shanghai OPM Biosciences Co Operating Margin %?

Shanghai OPM Biosciences Co SHSE:688293 -0.35% 82 Operating Margin % is 8.16% as of Mar. 2026, which is 11% below its 10-year median of 9.19. GuruFocus rates SHSE:688293 with a GF Score™ of 82/100 and a GF Value™ of ¥37.48 (Fairly Valued). The stock has 7 warning signs investors should review. Among 945 Biotechnology companies, Shanghai OPM Biosciences Co ranks better than 78.52% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Shanghai OPM Biosciences Co's Operating Income for the three months ended in Mar. 2026 was ¥14.9 Mil. Shanghai OPM Biosciences Co's Revenue for the three months ended in Mar. 2026 was ¥182.2 Mil. Therefore, Shanghai OPM Biosciences Co's Operating Margin % for the quarter that ended in Mar. 2026 was 8.16%.

Warning Sign:

Shanghai OPM Biosciences Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -10.8%.

The historical rank and industry rank for Shanghai OPM Biosciences Co's Operating Margin % or its related term are showing as below:

SHSE:688293' s Operating Margin % Range Over the Past 10 Years
Min: -124.93   Med: 9.19   Max: 35.29
Current: 7.58


SHSE:688293's Operating Margin % is ranked better than
78.52% of 945 companies
in the Biotechnology industry
Industry Median: -86.77 vs SHSE:688293: 7.58

Shanghai OPM Biosciences Co's 5-Year Average Operating Margin % Growth Rate was -10.80% per year.

Shanghai OPM Biosciences Co's Operating Income for the three months ended in Mar. 2026 was ¥14.9 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ¥34.4 Mil.


Shanghai OPM Biosciences Co  (SHSE:688293) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Shanghai OPM Biosciences Co Operating Margin % Related Terms


Shanghai OPM Biosciences Co Operating Margin % Historical Data

* Premium members only.

The historical data trend for Shanghai OPM Biosciences Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai OPM Biosciences Co Operating Margin % Chart

Shanghai OPM Biosciences Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial 28.51 35.29 13.67 6.04 10.65

Shanghai OPM Biosciences Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.87 16.98 9.35 -6.27 8.16

SHSE:688293 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, Shanghai OPM Biosciences Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai OPM Biosciences Co Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai OPM Biosciences Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai OPM Biosciences Co's Operating Margin % falls into.


SHSE:688293
82GF Score
Shanghai OPM Biosciences Co Ltd SHSE:688293
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai OPM Biosciences Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Shanghai OPM Biosciences Co's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=37.811 / 354.913
=10.65 %

Shanghai OPM Biosciences Co's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=14.861 / 182.155
=8.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 8.16% mean?
Shanghai OPM Biosciences Co (SHSE:688293) has a Operating Margin % of 8.16% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai OPM Biosciences Co and its competitors. This is 11% below median its historical median of 9.19. According to the industry distribution chart, Shanghai OPM Biosciences Co ranks #203 out of 945 companies in the Biotechnology industry, placing it in the top 21.5%.
Is Shanghai OPM Biosciences Co's Operating Margin % too high?
Shanghai OPM Biosciences Co's current Operating Margin % of 8.16% is 11% below median its 10-year median of 9.19. Based on the distribution chart, Shanghai OPM Biosciences Co ranks #203 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai OPM Biosciences Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai OPM Biosciences Co's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai OPM Biosciences Co ranks #203 out of 945 companies for Operating Margin %. This places Shanghai OPM Biosciences Co in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Shanghai OPM Biosciences Co and its competitors. Shanghai OPM Biosciences Co's current Operating Margin % is 8.16%, which is 11% below median its own 10-year median of 9.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai OPM Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai OPM Biosciences Co (SHSE:688293) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.48, compared to a current price of ¥40.09 — trading 7% above its estimated fair value. The current Operating Margin % is 8.16%, which is 11% below median its 10-year median of 9.19. Shanghai OPM Biosciences Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Shanghai OPM Biosciences Co (SHSE:688293), the current Operating Margin % is 8.16% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai OPM Biosciences Co (SHSE:688293) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai OPM Biosciences Co stock appears to be overvalued. The current stock price of ¥40.09 is trading 7% above its estimated GF Value™ of ¥37.48. GuruFocus considers Shanghai OPM Biosciences Co to be Fairly Valued.

Key valuation signals for SHSE:688293:

  • Operating Margin %: 8.16% (11% below median its 10-year median of 9.19)
  • GF Value™: ¥37.48 vs. price of ¥40.09 (7% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688293 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai OPM Biosciences Co Business Description

Address No. 28, Lane 908, Ziping Road, Pudong New Area, Shanghai, CHN, 201321
Shanghai OPM Biosciences Co Ltd is a biotechnology company specializing in providing cell culture solutions and comprehensive CDMO services.
82GF Score

Get the complete analysis for SHSE:688293

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥40.09
Price
¥37.48
GF Value